Myeloma Today Spring 2018 Volume 18 Number 2

Dear Reader

• A message from IMF President Susie Novis

Scientific & Clinical

• Immunotherapy in Myeloma: Monoclonal Antibodies
• FDA Expands Approval of Xgeva in Patients with Myeloma
• Updates on Drug Therapies for Multiple Myeloma

Education & Awareness

• IMF Reaches Out to Community Healthcare Providers

Special Event

• 2018 Myeloma Action Month!

Member Events

• A 5K Walk to Support the Work That Wins the Battle
• There Is No Such Thing As a Drop in the Bucket

Advocacy

• Advocacy Team Gives Greater Voice to Myeloma Patients’ Needs

International Partners

• IMF Holds Another Successful Patient & Family Seminar in Italy

 

Click here to download Myeloma Today
 

---

with support from:
Amgen, Celgene, Genentech, Janssen, and Takeda Oncology